Cary, North Carolina (PRWEB) April 28, 2015
TrialCard, the Association for Corporate Growth, Raleigh-Durham Deal of the Year winner, has announced it will participate in the upcoming Armada Specialty Pharmacy Summit, May 4-8 in Las Vegas. The annual event is the largest conference in the specialty pharmacy industry, connecting thousands of leaders from pharmacy providers, pharma and biotech manufacturers, and payers. Attendees participate in educational workshops and expert-led discussions that focus on current trends and issues facing the $100+ billion specialty pharmacy channel.
TrialCard will support the event as a Gold Sponsor, further solidifying its leadership in the market access space. Earlier this year the company announced its Market Access Solutions suite of offerings, which provides full-spectrum support to specialty manufacturers including reimbursement assistance, case management, nursing outreach, share of voice, and adherence and abandonment solutions. “For years we have been helping specialty manufacturers overcome their challenges in these areas to drive positive outcomes,” shared TrialCard President and CEO Mark Bouck. “With specialty drugs having so many touch points along the patient journey it only makes sense for our clients that we offer them a comprehensive package of solutions to successfully navigate this complex landscape.”
TrialCard’s contribution to the event will focus heavily on its strategic guidance and comprehensive product access and support solutions aimed at optimizing the patient and provider experience while enhancing outcomes for specialty medicines.
About TrialCard Incorporated
Founded in 2000, TrialCard Incorporated has become the largest provider of patient access programs in the industry, processing over $1 billion in reimbursement benefits per year. TrialCard holds nine US patents related to the processing and marketing of patient access programs. The company is headquartered in Cary, North Carolina. For more information about TrialCard, please visit http://www.trialcard.com.